Search results
Results from the WOW.Com Content Network
The Juravinski Cancer Centre (JCC) is a comprehensive centre for cancer care and cancer research in Hamilton, Ontario, Canada. Operated by Hamilton Health Sciences , it is adjacent to the Juravinski Hospital , which provides emergency department facilities.
The Royal Victoria Regional Health Centre is a 299-bed acute care facility. With a team of over 380 physicians, 2,500 staff members and 850 volunteers, [ 11 ] the RVH provides healthcare specializing in cancer care, surgical services , critical care , mental health rehabilitation services, as well as women and children's programs .
The Princess Margaret Cancer Centre (previously, Princess Margaret Hospital) is a scientific research centre and a teaching hospital in Toronto, Ontario, Canada, affiliated with the University of Toronto Faculty of Medicine as part of the University Health Network.
Complex continuing care, rehabilitation and the Waterloo-Wellington breast centre are located at this site. In November 2010, a new Specialized Mental Health program opened at Freeport, with all clinical practice based on the Recovery philosophy. This service is for patients living with severe and persistent mental illness, who would have ...
The new name is Ontario Shores Centre for Mental Health Sciences (Ontario Shores). The Communications and Public Affairs team at Ontario Shores won a Gold Quill Award of Merit in the category of Brand Communication from the International Association of Business Communicators (IABC) for the organization's rebranding project, A New Brand for a ...
Juravinski Hospital and Cancer Centre is a full-service general hospital offering cancer care, orthopedics and hepatobiliary surgery. The site's focus is cancer care services, with programs ranging from prevention, screening and diagnosis to treatment including chemotherapy and the region's only radiation treatment program.
Staging breast cancer is the initial step to help physicians determine the most appropriate course of treatment. As of 2016, guidelines incorporated biologic factors, such as tumor grade, cellular proliferation rate, estrogen and progesterone receptor expression, human epidermal growth factor 2 (HER2) expression, and gene expression profiling into the staging system.
This page was last edited on 27 September 2019, at 08:50 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.